These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1116 related articles for article (PubMed ID: 11261621)
21. Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach. Tuech JJ; Pessaux P; Di Fiore F; Nitu V; Lefebure B; Colson A; Michot F Eur J Surg Oncol; 2006 Mar; 32(2):158-61. PubMed ID: 16376515 [TBL] [Abstract][Full Text] [Related]
22. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Di Stefano AB; Acquaviva G; Garozzo G; Barbic M; Cvjeticanin B; Meglic L; Kobal B; Rakar S Gynecol Oncol; 2005 Dec; 99(3):671-9. PubMed ID: 16129476 [TBL] [Abstract][Full Text] [Related]
23. Ex vivo lymphatic mapping: a technique to improve pathologic staging in colorectal cancer. Broderick-Villa G; Amr D; Haigh PI; O'Connell TX; Danial T; Difronzo LA Am Surg; 2004 Nov; 70(11):937-41. PubMed ID: 15586501 [TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node mapping in colon cancer: current status. de Haas RJ; Wicherts DA; Hobbelink MG; Borel Rinkes IH; Schipper ME; van der Zee JA; van Hillegersberg R Ann Surg Oncol; 2007 Mar; 14(3):1070-80. PubMed ID: 17206482 [TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method? Rubello D; Nanni C; Merante Boschin I; Toniato A; Piotto A; Rampin L; Mariani G; Al-Nahhas A; Pelizzo MR J Exp Clin Cancer Res; 2006 Dec; 25(4):483-6. PubMed ID: 17310837 [TBL] [Abstract][Full Text] [Related]
26. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229 [TBL] [Abstract][Full Text] [Related]
27. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization. Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R Breast J; 2008; 14(1):61-7. PubMed ID: 18186867 [TBL] [Abstract][Full Text] [Related]
28. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Bilchik AJ; Saha S; Tsioulias GJ; Wood TF; Morton DL Ann Surg Oncol; 2001 Oct; 8(9 Suppl):82S-85S. PubMed ID: 11599909 [TBL] [Abstract][Full Text] [Related]
29. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer. Faerden AE; Sjo OH; Andersen SN; Hauglann B; Nazir N; Gravdehaug B; Moberg I; Svinland A; Nesbakken A; Bakka A Dis Colon Rectum; 2008 Jun; 51(6):891-6. PubMed ID: 18259817 [TBL] [Abstract][Full Text] [Related]
30. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum. Wong JH; Johnson DS; Namiki T; Tauchi-Nishi P Ann Surg Oncol; 2004 Aug; 11(8):772-7. PubMed ID: 15249341 [TBL] [Abstract][Full Text] [Related]
31. Clinical value of sentinel node mapping in carcinoma of the colon. Retter SM; Herrmann G; Schiedeck TH Colorectal Dis; 2011 Aug; 13(8):855-9. PubMed ID: 20456461 [TBL] [Abstract][Full Text] [Related]
32. RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients. Kelder W; van den Berg A; van der Leij J; Bleeker W; Tiebosch AT; Grond JK; Baas PC; Plukker JT Scand J Gastroenterol; 2006 Sep; 41(9):1073-8. PubMed ID: 16938721 [TBL] [Abstract][Full Text] [Related]
33. Predictive model of outcome of targeted nodal assessment in colorectal cancer. Nissan A; Protic M; Bilchik A; Eberhardt J; Peoples GE; Stojadinovic A Ann Surg; 2010 Feb; 251(2):265-74. PubMed ID: 20054276 [TBL] [Abstract][Full Text] [Related]
34. Validation of sentinel node mapping in patients with colon cancer. Paramo JC; Summerall J; Poppiti R; Mesko TW Ann Surg Oncol; 2002 Jul; 9(6):550-4. PubMed ID: 12095970 [TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Read TE; Fleshman JW; Caushaj PF Dis Colon Rectum; 2005 Jan; 48(1):80-5. PubMed ID: 15690662 [TBL] [Abstract][Full Text] [Related]
37. Intraoperative sentinel lymph node mapping in patients with colon cancer. Paramo JC; Summerall J; Wilson C; Cabral A; Willis I; Wodnicki H; Poppiti R; Mesko TW Am J Surg; 2001 Jul; 182(1):40-3. PubMed ID: 11532413 [TBL] [Abstract][Full Text] [Related]
38. Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial. Weixler B; Rickenbacher A; Raptis DA; Viehl CT; Guller U; Rueff J; Zettl A; Zuber M World J Surg; 2017 Sep; 41(9):2378-2386. PubMed ID: 28508233 [TBL] [Abstract][Full Text] [Related]
39. [The intraoperative study of the sentinel lymph node was made possible through molecular analysis: a new concept and new applications for colon cancer?]. Coget J; Pocard M Bull Cancer; 2014 Apr; 101(4):364-7. PubMed ID: 24793628 [TBL] [Abstract][Full Text] [Related]
40. Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients. Weixler B; Warschkow R; Zettl A; Riehle HM; Guller U; Viehl CT; Zuber M World J Surg; 2015 Oct; 39(10):2583-9. PubMed ID: 26154574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]